Startseite HbG200-mediated preinduction of heme oxygenase-1 improves bile flow and ameliorates pericentral downregulation of Bsep and Mrp2 following experimental liver ischemia and reperfusion
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

HbG200-mediated preinduction of heme oxygenase-1 improves bile flow and ameliorates pericentral downregulation of Bsep and Mrp2 following experimental liver ischemia and reperfusion

  • Markus G. Donner EMAIL logo , Stefan A. Topp , Patricia Cebula , Anna Krienen , Thor Gehrmann , Annika Sommerfeld , Roland Reinehr , Arne Macher , Diran Herebian , Ertan Mayatepek , Benedikt H. Pannen , Wolfram T. Knoefel und Dieter Häussinger
Veröffentlicht/Copyright: 4. Dezember 2012

Abstract

We studied the downregulation of hepatobiliary transport systems and the effect of pharmacological heme oxygenase-1 (HO-1) preinduction by Hemoglobin-Glutamer 200 (HbG200) in cold ischemia-reperfused rat liver (I/R). Cold I/R reduced bile flow in the reperfusion period from 3.10±0.10 ml/3 h to 0.54±0.20 ml/3 h (p<0.05) and biliary taurocholate excretion from 45.9±13.81 μmol/3 h to 1.87±0.46 μmol/3 h (p<0.05). Mrp2, Bsep and Ntcp peak immunofluorescence in pericentral hepatocytes decreased to 79.0±2.6% (p<0.001), 80.6±8.4% (p<0.05) and 65.8±5.0% (p<0.01), respectively. Pre-induction of HO-1 by HbG200 was largely confined to pericentral hepatocytes. HO-1 induction attenuated the decreased bile flow (0.91±0.16 ml/3 h, p<0.05) and canalicular taurocholate secretion (4.33±1.71 μmol/3 h, p<0.05). Bsep and Mrp2 peak immunofluorescence in pericentral hepatocytes was largely restored. Activation of JNK and Fyn by cold I/R was significantly attenuated by HO-1. Inhibiting HO activity by tin protoporphyrin IX after HbG200 administration reversed the effect on bile flow and canalicular transporter expression. In conclusion, pericentral downregulation of Bsep and Mrp2 following cold I/R is ameliorated by inducing HO-1 and was associated with diminished hepatocellular JNK and Fyn signaling. HO-1 may serve as a therapeutic target to attenuate hepatocellular cholestasis following I/R injury.


Corresponding author: Markus G. Donner, Department of Gastroenterology, Hepatology and Infectious Diseases, Heinrich Heine University Düsseldorf, D-40225 Düsseldorf, Germany

Received: 2012-3-14
Accepted: 2012-8-2
Published Online: 2012-12-04
Published in Print: 2013-01-01

©2012 by Walter de Gruyter Berlin Boston

Heruntergeladen am 21.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/hsz-2012-0153/html
Button zum nach oben scrollen